SG11201903443QA - Composite particles including anionic polymer and cationic polymer or peptide, and method for producing composite particles - Google Patents
Composite particles including anionic polymer and cationic polymer or peptide, and method for producing composite particlesInfo
- Publication number
- SG11201903443QA SG11201903443QA SG11201903443QA SG11201903443QA SG11201903443QA SG 11201903443Q A SG11201903443Q A SG 11201903443QA SG 11201903443Q A SG11201903443Q A SG 11201903443QA SG 11201903443Q A SG11201903443Q A SG 11201903443QA SG 11201903443Q A SG11201903443Q A SG 11201903443QA
- Authority
- SG
- Singapore
- Prior art keywords
- composite particles
- peptide
- polymer
- anionic polymer
- cationic polymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0283—Matrix particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mathematical Physics (AREA)
- Medical Informatics (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016203809A JP6901841B2 (ja) | 2016-10-17 | 2016-10-17 | アニオン性ポリマー及びペプチドを含む複合粒子及びその製造方法 |
JP2016204693A JP6956478B2 (ja) | 2016-10-18 | 2016-10-18 | アニオン性ポリマー及びカチオン性ポリマーを含む複合粒子 |
PCT/JP2017/036146 WO2018074237A1 (ja) | 2016-10-17 | 2017-10-04 | アニオン性ポリマー及びカチオン性ポリマー若しくはペプチドを含む複合粒子並びにその製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201903443QA true SG11201903443QA (en) | 2019-05-30 |
Family
ID=62019641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201903443QA SG11201903443QA (en) | 2016-10-17 | 2017-10-04 | Composite particles including anionic polymer and cationic polymer or peptide, and method for producing composite particles |
Country Status (9)
Country | Link |
---|---|
US (2) | US11707419B2 (de) |
EP (2) | EP3799858A1 (de) |
KR (3) | KR102215375B1 (de) |
CN (3) | CN113995731A (de) |
ES (1) | ES2971884T3 (de) |
MY (1) | MY192816A (de) |
SG (1) | SG11201903443QA (de) |
TW (1) | TWI784978B (de) |
WO (1) | WO2018074237A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3799858A1 (de) * | 2016-10-17 | 2021-04-07 | Pola Chemical Industries Inc. | Verfahren zur herstellung von verbundteilchen |
KR102099842B1 (ko) * | 2019-09-26 | 2020-04-10 | (주)리젠바이오참 | 조직재생용 하이드로겔 조성물 및 이를 이용하여 제조된 지지체 |
JP2021095361A (ja) * | 2019-12-17 | 2021-06-24 | ロレアル | ヒアルロン酸系ポリイオンコンプレックス粒子を含む組成物 |
US20230149683A1 (en) * | 2020-02-24 | 2023-05-18 | B. G. Negev Technologies and Applications Itd., at Ben-Gurion university | Methods for Enhancing Transdermal and Intradermal Delivery of Glycosaminoglycans (GAGs) |
CN112063221B (zh) * | 2020-09-18 | 2022-11-15 | 山东华熙海御生物医药有限公司 | 含透明质酸的着色助剂、制法及其应用 |
US20240033201A1 (en) * | 2020-12-14 | 2024-02-01 | L'oreal | Composition comprising polyion complex particle and filler |
FR3118700A1 (fr) * | 2021-01-13 | 2022-07-15 | L'oreal | Composition comprenant une particule de complexe polyionique et une charge |
CN114699335B (zh) * | 2022-04-25 | 2023-11-03 | 广州创尔生物技术股份有限公司 | 一种稳定的胶原蛋白-透明质酸互溶体系及其制备方法 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7056338B2 (en) * | 2003-03-28 | 2006-06-06 | Conor Medsystems, Inc. | Therapeutic agent delivery device with controlled therapeutic agent release rates |
ES2226567B1 (es) * | 2003-06-20 | 2006-07-01 | Universidad De Santiago De Compostela | Nanoparticulas de acido hialuronico. |
JP4461727B2 (ja) * | 2003-07-18 | 2010-05-12 | チッソ株式会社 | 外用剤組成物 |
WO2005089106A2 (en) * | 2004-02-27 | 2005-09-29 | Molecular Therapeutics, Inc. | Degradable nanoparticles |
ES2259914B1 (es) | 2005-03-14 | 2007-06-16 | Advanced In Vitro Cell Technologies, S.L. | Nanoparticulas de quitosano y polietilenglicol como sistema de administracion de moleculas biologicamente activas. |
US20070110813A1 (en) * | 2005-11-02 | 2007-05-17 | Aeris Therapeutics, Inc. | Polycation-polyanion complexes, compositions and methods of use thereof |
CN101448939B (zh) | 2006-05-17 | 2011-12-14 | 小山义之 | 用于导入核酸、寡核酸或其衍生物的冷冻干燥体 |
KR20090031861A (ko) | 2006-05-24 | 2009-03-30 | 어드밴스드 인 비트로 셀 테크놀로지스, 에스.에이 | 활성분자의 투여를 위한 키토산 및 하이알루로난 나노입자 |
EP2166022B1 (de) * | 2007-04-24 | 2016-09-21 | Q.P. Corporation | Kationisierte hyaluronsäure und/oder salz davon, herstellungsverfahren dafür und haarmodfizierungsmittel, mittel zur reparatur der kutikulaschicht, hautmodifizierungsmittel und kosmetische zubereitung mit diesen |
JP5085976B2 (ja) * | 2007-05-09 | 2012-11-28 | 株式会社 資生堂 | 球状複合ゲル粒子の製造方法 |
EP2152293B1 (de) | 2007-05-11 | 2016-10-19 | The Board of Regents of the University of Nebraska | Zusammensetzungen zur proteinabgabe und verfahren zu deren verwendung |
WO2009079066A2 (en) * | 2007-09-26 | 2009-06-25 | Aparna Biosciences | Therapeutic and vaccine polyelectrolyte nanoparticle compositions |
US8093365B2 (en) * | 2008-03-03 | 2012-01-10 | New York University | Biocompatible materials containing stable complexes method of TSG-6 and hyaluronan and method of using same |
EP2172193A1 (de) | 2008-10-02 | 2010-04-07 | Capsulution Nanoscience AG | Verbesserte Nanopartikel-Zusammensetzungen schlecht löslicher Verbindungen |
US20110256059A1 (en) * | 2008-10-28 | 2011-10-20 | Universidade De Santiago De Compostela | Nanoparticulate systems prepared from anionic polymers |
US9028797B2 (en) * | 2010-02-26 | 2015-05-12 | Nagasaki University | Composite body for antigen or drug delivery |
CN102210871A (zh) * | 2010-07-16 | 2011-10-12 | 钟术光 | 缓释释药的药物载体 |
JP6292655B2 (ja) | 2012-10-11 | 2018-03-14 | ポーラ化成工業株式会社 | キトサン及びヒアルロナンを含むナノ粒子 |
JP6162943B2 (ja) * | 2012-11-02 | 2017-07-12 | ポーラ化成工業株式会社 | ヒアルロナンを含むナノ粒子 |
EP3024887B1 (de) * | 2013-07-26 | 2023-11-22 | The Penn State Research Foundation | Verfahren zur herstellung von polymerzusammensetzungen und beschichtungen damit |
EP3064213A4 (de) * | 2013-10-28 | 2017-04-26 | Terumo Kabushiki Kaisha | Wässrige proteinsuspension |
WO2015189387A1 (en) | 2014-06-13 | 2015-12-17 | Sanofi | Nanocapsular formulation of active pharmaceutical ingredients |
JP6602626B2 (ja) | 2015-09-28 | 2019-11-06 | 嘉寛 徳留 | ヒアルロナンを含む複合粒子を含有する乳化組成物 |
CN105726511A (zh) * | 2016-03-10 | 2016-07-06 | 温州医科大学 | 一种自发组装的多聚赖氨酸接枝物纳米粒及其制备与应用 |
EP3799858A1 (de) * | 2016-10-17 | 2021-04-07 | Pola Chemical Industries Inc. | Verfahren zur herstellung von verbundteilchen |
-
2017
- 2017-10-04 EP EP20209142.7A patent/EP3799858A1/de active Pending
- 2017-10-04 WO PCT/JP2017/036146 patent/WO2018074237A1/ja active Application Filing
- 2017-10-04 EP EP17861460.8A patent/EP3527194B1/de active Active
- 2017-10-04 US US16/340,350 patent/US11707419B2/en active Active
- 2017-10-04 CN CN202111282634.7A patent/CN113995731A/zh active Pending
- 2017-10-04 CN CN201780063620.1A patent/CN109862876B/zh active Active
- 2017-10-04 KR KR1020197011828A patent/KR102215375B1/ko active IP Right Grant
- 2017-10-04 KR KR1020207030107A patent/KR102301452B1/ko active IP Right Grant
- 2017-10-04 ES ES17861460T patent/ES2971884T3/es active Active
- 2017-10-04 KR KR1020207030108A patent/KR102301456B1/ko active IP Right Grant
- 2017-10-04 MY MYPI2019002074A patent/MY192816A/en unknown
- 2017-10-04 CN CN202210682785.XA patent/CN115192468B/zh active Active
- 2017-10-04 SG SG11201903443QA patent/SG11201903443QA/en unknown
- 2017-10-16 TW TW106135326A patent/TWI784978B/zh active
-
2020
- 2020-05-28 US US16/886,001 patent/US12029800B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR20190059303A (ko) | 2019-05-30 |
KR102301456B1 (ko) | 2021-09-10 |
ES2971884T3 (es) | 2024-06-10 |
KR102301452B1 (ko) | 2021-09-10 |
TWI784978B (zh) | 2022-12-01 |
EP3527194A1 (de) | 2019-08-21 |
US20190231655A1 (en) | 2019-08-01 |
CN109862876A (zh) | 2019-06-07 |
EP3799858A1 (de) | 2021-04-07 |
EP3527194A4 (de) | 2020-08-19 |
KR20200123274A (ko) | 2020-10-28 |
CN115192468A (zh) | 2022-10-18 |
EP3527194B1 (de) | 2024-02-14 |
WO2018074237A1 (ja) | 2018-04-26 |
US20200289380A1 (en) | 2020-09-17 |
EP3527194C0 (de) | 2024-02-14 |
MY192816A (en) | 2022-09-09 |
CN115192468B (zh) | 2024-02-13 |
TW201828916A (zh) | 2018-08-16 |
US11707419B2 (en) | 2023-07-25 |
US12029800B2 (en) | 2024-07-09 |
KR102215375B1 (ko) | 2021-02-15 |
CN109862876B (zh) | 2022-07-22 |
CN113995731A (zh) | 2022-02-01 |
KR20200122431A (ko) | 2020-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201903443QA (en) | Composite particles including anionic polymer and cationic polymer or peptide, and method for producing composite particles | |
WO2016196315A3 (en) | Cell culture methods and systems | |
MX2016003740A (es) | Particulas de dioxido de titanio y un proceso para su produccion. | |
MX2015017526A (es) | Método para la fabricación de un producto perfilado de ácido hialurónico. | |
SA516380356B1 (ar) | مشتتات مطلية من ثاني أكسيد التيتانيوم | |
PH12018502469A1 (en) | Molecular modification of polyethylene resin | |
MX2017010882A (es) | Un producto de concreto fotocatalitico y un metodo para generar un producto de concreto fotocatalitico. | |
WO2016193351A3 (en) | Recombinant microorganism for improved production of fine chemicals | |
EP3590970A4 (de) | Fasercellulose, fasercellulosehaltige zusammensetzung, flüssige dispersion von fasercellulose und verfahren zur herstellung von fasercellulose | |
WO2019023057A3 (en) | TREATMENT OF MINERAL OR STERILE RESIDUES OF PHOSPHATES | |
MX2011007731A (es) | Pigmentos formadores de pelicula y sistema de recubrimiento que incluye los mismos. | |
MY191789A (en) | Production of glycolaldehyde by thermolytic fragmentation | |
EP3680290A4 (de) | Cellulosenanofaserflüssigdispersion, cellulosenanofaserverbundharz und verfahren zur herstellung von dispersion und harz | |
MX2019008977A (es) | Tratamiento de composiciones acuosas que incluyen finos. | |
BR112018076542A2 (pt) | método para preparar partículas contendo celulose | |
EP3238548A4 (de) | Verfahren zur herstellung von rohpillen aus fermentierten mineralien mit funktion zur verbesserung von darmverstopfung und erholung von erschöpfungszuständen sowie damit hergestellte rohpillen aus fermentierten mineralien | |
EP3275919A4 (de) | Wässrige dispersion aus gelpartikeln, verfahren zur herstellung davon und bilderzeugungsverfahren | |
WO2009041275A1 (ja) | 樹脂微粒子水分散体の製造方法及びこの製造方法にて得られた樹脂微粒子水分散体、樹脂微粒子 | |
MX2015003203A (es) | Proceso para mejorar las propiedades reologicas de una dispersion acuosa. | |
WO2019095024A3 (en) | Method for production of microcrystalline cellulose | |
WO2019018370A3 (en) | TREATMENT OF BITUMINOUS SAND RESIDUES | |
SE1751603A1 (en) | Improved process for manufacturing composite product | |
EP3222667A4 (de) | Sphärische monodispersible wässrige polyesterharzdispersion, verfahren zur herstellung davon, sphärischer monodispersibler polyesterharzpartikel und kosmetikprodukt | |
WO2018110846A3 (ko) | 기능화된 그래핀의 제조 방법 | |
MX2015011383A (es) | Particulas opacificantes con hueco interno y metodos para la fabricacion de las mismas. |